B-intervention	0	8	Axillary
I-intervention	9	13	node
I-intervention	14	22	sampling
I-intervention	23	25	in
I-intervention	26	37	conjunction
I-intervention	38	42	with
I-intervention	43	51	sentinel
I-intervention	52	56	node
I-intervention	57	63	biopsy
O	64	66	in
O	67	75	patients
O	76	80	with
O	81	87	breast
O	88	94	cancer
O	94	95	.

O	96	97	A
O	98	109	prospective
O	110	121	preliminary
O	122	127	study
O	127	128	.

O	129	131	In
O	132	140	patients
O	141	145	with
O	146	152	breast
O	153	159	cancer
O	160	161	(
O	161	163	BC
O	163	164	)
O	164	165	,
O	166	174	axillary
O	175	180	lymph
O	181	185	node
O	186	194	sampling
O	195	196	(
O	196	200	ALNS
O	200	201	)
O	202	204	is
O	205	206	a
O	207	215	reliable
O	216	225	procedure
O	226	230	with
O	231	234	low
O	235	244	morbidity
O	244	245	,
O	246	257	alternative
O	258	260	or
O	261	274	complementary
O	275	277	to
O	278	286	sentinel
O	287	292	lymph
O	293	297	node
O	298	304	biopsy
O	305	306	(
O	306	310	SLNB
O	310	311	)
O	311	312	,
O	313	318	which
O	319	322	may
O	323	330	improve
O	331	334	the
O	335	344	detection
O	345	349	rate
O	350	352	of
O	353	361	axillary
O	362	366	node
O	367	377	metastases
O	378	380	as
O	381	389	compared
O	390	392	to
O	393	397	SLNB
O	398	403	alone
O	404	406	in
O	407	414	staging
O	415	418	the
O	419	425	axilla
O	425	426	.

O	427	430	The
O	431	434	aim
O	435	437	of
O	438	442	this
O	443	448	study
O	449	452	was
O	453	455	to
O	456	462	assess
O	463	466	the
O	467	477	usefulness
O	478	480	of
O	481	485	ALNS
O	486	488	in
O	489	500	conjunction
O	501	505	with
O	506	510	SLNB
O	511	513	in
O	514	523	improving
O	524	527	the
O	528	539	sensitivity
O	540	542	of
O	543	547	SLNB
O	548	553	alone
O	554	556	at
O	557	563	frozen
O	564	571	section
O	572	583	examination
O	583	584	.

B-total-participants	585	588	One
I-total-participants	589	596	hundred
I-total-participants	597	600	and
I-total-participants	601	607	twelve
O	608	613	women
O	614	615	(
O	615	621	median
O	622	625	age
B-age	626	628	56
I-age	629	634	years
O	634	635	,
O	636	641	range
O	642	644	29
O	644	645	-
O	645	647	71
O	648	653	years
O	653	654	)
B-eligibility	655	659	with
I-eligibility	660	662	BC
I-eligibility	663	672	underwent
I-eligibility	673	677	SLNB
I-eligibility	678	683	using
I-eligibility	684	685	a
I-eligibility	686	694	combined
I-eligibility	695	707	radioisotope
I-eligibility	708	711	and
I-eligibility	712	721	isosulfan
I-eligibility	722	726	blue
I-eligibility	727	730	dye
I-eligibility	731	740	technique
O	740	741	.

O	742	745	Two
O	746	752	groups
O	753	755	of
O	756	759	age
O	759	760	-
O	761	764	and
O	765	770	tumor
O	771	775	size
O	775	776	-
O	776	783	matched
O	784	792	patients
O	793	797	were
O	798	811	prospectively
O	812	822	randomized
O	822	823	:
O	824	829	Group
O	830	831	A
O	832	833	(
B-control	833	837	SLNB
I-control	838	843	alone
O	843	844	,
B-control-participants	845	847	55
O	848	853	women
O	853	854	)
O	855	858	and
O	859	864	group
O	865	866	B
O	867	868	(
O	868	872	SLNB
O	873	877	plus
O	878	882	ALNS
O	882	883	,
B-intervention-participants	884	886	57
O	887	892	women
O	892	893	)
O	893	894	.

O	895	909	Intraoperative
O	910	921	examination
O	922	928	showed
B-outcome	929	931	SN
I-outcome	932	943	involvement
O	944	946	in
O	947	949	32
O	950	951	(
O	951	953	28
O	953	954	.
O	954	955	6
O	955	956	%
O	956	957	)
O	958	966	patients
O	966	967	:
O	968	973	group
O	974	975	A
O	976	977	=
B-cv-bin-abs	978	980	14
O	981	982	(
B-cv-bin-percent	982	984	25
I-cv-bin-percent	984	985	.
I-cv-bin-percent	985	986	5
I-cv-bin-percent	986	987	%
O	987	988	)
O	988	989	,
O	990	995	group
O	996	997	B
O	998	999	=
B-iv-bin-abs	1000	1002	18
O	1003	1004	(
B-iv-bin-percent	1004	1006	31
I-iv-bin-percent	1006	1007	.
I-iv-bin-percent	1007	1008	6
I-iv-bin-percent	1008	1009	%
O	1009	1010	)
O	1010	1011	,
O	1012	1018	whilst
O	1019	1022	the
O	1023	1028	final
O	1029	1038	pathology
O	1039	1045	showed
B-outcome	1046	1054	axillary
I-outcome	1055	1059	node
I-outcome	1060	1071	involvement
O	1072	1074	in
O	1075	1076	7
O	1077	1084	further
O	1085	1090	cases
O	1091	1092	(
O	1092	1097	group
O	1098	1099	A
O	1100	1101	=
B-cv-bin-abs	1102	1103	5
O	1103	1104	,
O	1105	1110	group
O	1111	1112	B
O	1113	1114	=
B-iv-bin-abs	1115	1116	2
O	1116	1117	)
O	1117	1118	.

O	1119	1122	The
B-outcome	1123	1134	sensitivity
O	1135	1138	and
B-outcome	1139	1147	accuracy
O	1148	1152	were
B-cv-bin-percent	1153	1155	73
I-cv-bin-percent	1155	1156	.
I-cv-bin-percent	1156	1157	7
I-cv-bin-percent	1157	1158	%
O	1159	1161	vs
O	1161	1162	.
B-iv-bin-percent	1163	1165	90
I-iv-bin-percent	1165	1166	.
I-iv-bin-percent	1166	1167	0
I-iv-bin-percent	1167	1168	%
O	1169	1170	(
O	1170	1171	p
O	1172	1173	=
O	1174	1175	0
O	1175	1176	.
O	1176	1178	23
O	1178	1179	)
O	1180	1183	and
B-cv-bin-percent	1184	1186	90
I-cv-bin-percent	1186	1187	.
I-cv-bin-percent	1187	1188	9
I-cv-bin-percent	1188	1189	%
O	1190	1192	vs
O	1192	1193	.
B-iv-bin-percent	1194	1196	94
I-iv-bin-percent	1196	1197	.
I-iv-bin-percent	1197	1198	7
I-iv-bin-percent	1198	1199	%
O	1200	1201	(
O	1201	1202	p
O	1203	1204	=
O	1205	1206	0
O	1206	1207	.
O	1207	1209	49
O	1209	1210	)
O	1210	1211	,
O	1212	1217	group
O	1218	1219	A
O	1220	1222	vs
O	1222	1223	.
O	1224	1225	B
O	1225	1226	,
O	1227	1239	respectively
O	1239	1240	.

O	1241	1253	Multivariate
O	1254	1262	analysis
O	1263	1269	showed
O	1270	1274	that
O	1275	1278	age
O	1279	1280	>
O	1280	1282	65
O	1283	1288	years
O	1289	1292	and
O	1293	1297	body
O	1298	1302	mass
O	1303	1308	index
O	1309	1322	independently
O	1323	1333	correlated
O	1334	1338	with
O	1339	1342	the
B-outcome	1343	1349	amount
I-outcome	1350	1352	of
I-outcome	1353	1361	axillary
I-outcome	1362	1370	drainage
O	1371	1373	in
O	1374	1378	both
O	1379	1385	groups
O	1385	1386	,
O	1387	1392	which
O	1393	1396	was
B-cv-cont-mean	1397	1399	47
I-cv-cont-mean	1399	1400	.
I-cv-cont-mean	1400	1401	5
O	1402	1403	±
B-cv-cont-sd	1404	1406	11
I-cv-cont-sd	1406	1407	.
I-cv-cont-sd	1407	1408	3
O	1409	1412	and
B-iv-cont-mean	1413	1415	49
I-iv-cont-mean	1415	1416	.
I-iv-cont-mean	1416	1417	6
O	1418	1419	±
B-iv-cont-sd	1420	1422	12
I-iv-cont-sd	1422	1423	.
I-iv-cont-sd	1423	1424	2
I-iv-cont-sd	1425	1427	ml
O	1428	1429	(
O	1429	1430	A
O	1431	1433	vs
O	1433	1434	.
O	1435	1436	B
O	1436	1437	,
O	1438	1439	p
O	1440	1441	=
O	1442	1444	NS
O	1444	1445	)
O	1445	1446	,
O	1447	1459	respectively
O	1459	1460	.

O	1461	1463	In
O	1464	1474	conclusion
O	1474	1475	,
O	1476	1478	in
O	1479	1482	our
O	1483	1494	preliminary
O	1495	1500	study
O	1500	1501	,
O	1502	1506	ALNS
O	1507	1509	in
O	1510	1521	conjunction
O	1522	1526	with
O	1527	1531	SLNB
O	1532	1534	is
O	1535	1536	a
O	1537	1540	low
O	1540	1541	-
O	1541	1545	risk
O	1546	1555	procedure
O	1555	1556	,
O	1557	1563	useful
O	1564	1566	to
O	1567	1573	reduce
O	1574	1577	the
O	1578	1583	false
O	1583	1584	-
O	1584	1592	negative
O	1593	1597	rate
O	1598	1600	of
O	1601	1605	SLNB
O	1606	1609	and
O	1610	1612	to
O	1613	1620	improve
O	1621	1624	the
O	1625	1633	accuracy
O	1634	1636	of
O	1637	1651	intraoperative
O	1652	1662	evaluation
O	1663	1665	of
O	1666	1669	the
O	1670	1678	axillary
O	1679	1684	nodes
O	1685	1687	in
O	1688	1696	patients
O	1697	1701	with
O	1702	1704	BC
O	1704	1705	.
